|
1
|
Liebig C, Ayala G, Wilks JA, Berger DH and
Albo D: Perineural invasion in cancer: A review of the literature.
Cancer. 115:3379–3391. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lesnik DJ and Boey HP: Perineural invasion
of the facial nerve by a cutaneous squamous cell cancer: A case
report. Ear Nose Throat J 83. 824:826–827. 2004.
|
|
3
|
Gupta A, Veness M, De'Ambrosis B, Selva D
and Huilgol SC: Management of squamous cell and basal cell
carcinomas of the head and neck with perineural invasion. Australas
J Dermatol. 57:3–13. 2016. View Article : Google Scholar
|
|
4
|
Pour PM, Bell RH and Batra SK: Neural
invasion in the staging of pancreatic cancer. Pancreas. 26:322–325.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feng FY, Qian Y, Stenmark MH, Halverson S,
Blas K, Vance S, Sandler HM and Hamstra DA: Perineural invasion
predicts increased recurrence, metastasis, and death from prostate
cancer following treatment with dose-escalated radiation therapy.
Int J Radiat Oncol Biol Phys. 81:e361–e367. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liebig C, Ayala G, Wilks J, Verstovsek G,
Liu H, Agarwal N, Berger DH and Albo D: Perineural invasion is an
independent predictor of outcome in colorectal cancer. J Clin
Oncol. 27:5131–5137. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deng J, You Q, Gao Y, Yu Q, Zhao P, Zheng
Y, Fang W, Xu N and Teng L: Prognostic value of perineural invasion
in gastric cancer: A systematic review and meta-analysis. PLoS One.
9:e889072014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng SC, Zhang YR, Luo SY and Zhang LP:
The effect of GDNF on matrix-degrading and cell-adhesion during
perineural invasion of salivary adenoid cystic carcinoma. Shanghai
Kou Qiang Yi Xue. 25:212–216. 2016.In Chinese. PubMed/NCBI
|
|
9
|
Figueira RC, Gomes LR, Neto JS, Silva FC,
Silva ID and Sogayar MC: Correlation between MMPs and their
inhibitors in breast cancer tumor tissue specimens and in cell
lines with different metastatic potential. BMC Cancer. 9:202009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Batsakis JG: Nerves and neurotropic
carcinomas. Ann Otol Rhinol Laryngol. 94:426–427. 1985.PubMed/NCBI
|
|
11
|
Amit M, Na'ara S and Gil Z: Mechanisms of
cancer dissemination along nerves. Nat Rev Cancer. 16:399–408.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abbadie C: Chemokines, chemokine receptors
and pain. Trends Immunol. 26:529–534. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sommer C and Kress M: Recent findings on
how proinflammatory cytokines cause pain: Peripheral mechanisms in
inflammatory and neuropathic hyperalgesia. Neurosci Lett.
361:184–187. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Charo IF and Ransohoff RM: The many roles
of chemokines and chemokine receptors in inflammation. N Engl J
Med. 354:610–621. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Griffith JW, Sokol CL and Luster AD:
Chemokines and chemokine receptors: Positioning cells for host
defense and immunity. Annu Rev Immunol. 32:659–702. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Szekanecz Z, Vegvari A, Szabo Z and Koch
AE: Chemokines and chemokine receptors in arthritis. Front Biosci
(Schol Ed). 2:153–167. 2010. View
Article : Google Scholar
|
|
17
|
Gao YJ and Ji RR: Chemokines,
neuronal-glial interactions, and central processing of neuropathic
pain. Pharmacol Ther. 126:56–68. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rossi D and Zlotnik A: The biology of
chemokines and their receptors. Annu Rev Immunol. 18:217–242. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bonecchi R, Galliera E, Borroni EM, Corsi
MM, Locati M and Mantovani A: Chemokines and chemokine receptors:
An overview. Front Biosci (Landmark Ed). 14:540–551. 2009.
View Article : Google Scholar
|
|
20
|
Bryan SA, Jose PJ, Topping JR, Wilhelm R,
Soderberg C, Kertesz D, Barnes PJ, Williams TJ, Hansel TT and
Sabroe I: Responses of leukocytes to chemokines in whole blood and
their antagonism by novel CC-chemokine receptor 3 antagonists. Am J
Respir Crit Care Med. 165:1602–1609. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Old EA and Malcangio M: Chemokine mediated
neuron-glia communication and aberrant signalling in neuropathic
pain states. Curr Opin Pharmacol. 12:67–73. 2012. View Article : Google Scholar
|
|
22
|
Zlotnik A and Yoshie O: The chemokine
superfamily revisited. Immunity. 36:705–716. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lefkowitz RJ: Seven transmembrane
receptors: A brief personal retrospective. Biochim Biophys Acta.
1768:748–755. 2007. View Article : Google Scholar
|
|
24
|
Hamm HE: The many faces of G protein
signaling. J Biol Chem. 273:669–672. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Violin JD and Lefkowitz RJ:
Beta-arrestin-biased ligands at seven-transmembrane receptors.
Trends Pharmacol Sci. 28:416–422. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Curnock AP, Logan MK and Ward SG:
Chemokine signalling: Pivoting around multiple phosphoinositide
3-kinases. Immunology. 105:125–136. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
DeWire SM, Ahn S, Lefkowitz RJ and Shenoy
SK: Beta-arrestins and cell signaling. Annu Rev Physiol.
69:483–510. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Logothetis DE, Kurachi Y, Galper J, Neer
EJ and Clapham DE: The beta gamma subunits of GTP-binding proteins
activate the muscarinic K+ channel in heart. Nature.
325:321–326. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wilson J and Balkwill F: The role of
cytokines in the epithelial cancer microenvironment. Semin Cancer
Biol. 12:113–120. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brew R, Erikson JS, West DC, Flanagan BF
and Christmas SE: Interleukin-8 as a growth factor for human
colorectal carcinoma cells in vitro. Biochem Soc Trans.
25:S2641997. View Article : Google Scholar
|
|
31
|
Di Cesare S, Marshall JC, Logan P, Antecka
E, Faingold D, Maloney SC and Burnier MN Jr: Expression and
migratory analysis of 5 human uveal melanoma cell lines for CXCL12,
CXCL8, CXCL1, and HGF. J Carcinog. 6:22007.PubMed/NCBI
|
|
32
|
Liotta LA: An attractive force in
metastasis. Nature. 410:24–25. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Panda S, Padhiary SK and Routray S:
Chemokines accentuating protumoral activities in oral cancer
microenvironment possess an imperious stratagem for therapeutic
resolutions. Oral Oncol. 60:8–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang S, Qi L, Li M, Zhang D, Xu S, Wang N
and Sun B: Chemokine CXCL12 and its receptor CXCR4 expression are
associated with perineural invasion of prostate cancer. J Exp Clin
Cancer Res. 27:622008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He S, He S, Chen CH, Deborde S, Bakst RL,
Chernichenko N, McNamara WF, Lee SY, Barajas F, Yu Z, et al: The
chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.
Mol Cancer Res. 13:380–390. 2015. View Article : Google Scholar :
|
|
36
|
Shen Z, Li T, Chen D, Jia S, Yang X, Liang
L, Chai J, Cheng X, Yang X and Sun M: The CCL5/CCR5 axis
contributes to the perineural invasion of human salivary adenoid
cystic carcinoma. Oncol Rep. 31:800–806. 2014. View Article : Google Scholar
|
|
37
|
Marchesi F, Piemonti L, Mantovani A and
Allavena P: Molecular mechanisms of perineural invasion, a
forgotten pathway of dissemination and metastasis. Cytokine Growth
Factor Rev. 21:77–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dubový P, Klusáková I, Svízenská I and
Brázda V: Spatio-temporal changes of SDF1 and its CXCR4 receptor in
the dorsal root ganglia following unilateral sciatic nerve injury
as a model of neuropathic pain. Histochem Cell Biol. 133:323–337.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hart CA, Brown M, Bagley S, Sharrard M and
Clarke NW: Invasive characteristics of human prostatic epithelial
cells: Understanding the metastatic process. Br J Cancer.
92:503–512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schimanski CC, Bahre R, Gockel I, Müller
A, Frerichs K, Hörner V, Teufel A, Simiantonaki N, Biesterfeld S,
Wehler T, et al: Dissemination of hepatocellular carcinoma is
mediated via chemokine receptor CXCR4. Br J Cancer. 95:210–217.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kollmar O, Rupertus K, Scheuer C, Junker
B, Tilton B, Schilling MK and Menger MD: Stromal cell-derived
factor-1 promotes cell migration and tumor growth of colorectal
metastasis. Neoplasia. 9:862–870. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu Q, Wang Z, Chen X, Duan W, Lei J, Zong
L, Li X, Sheng L, Ma J, Han L, et al: Stromal-derived
factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural
invasion in pancreatic cancer. Oncotarget. 6:4717–4732.
2015.PubMed/NCBI
|
|
44
|
Kang H, Mansel RE and Jiang WG: Genetic
manipulation of stromal cell-derived factor-1 attests the pivotal
role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of
breast cancer cells. Int J Oncol. 26:1429–1434. 2005.PubMed/NCBI
|
|
45
|
Matteucci E, Locati M and Desiderio MA:
Hepatocyte growth factor enhances CXCR4 expression favoring breast
cancer cell invasiveness. Exp Cell Res. 310:176–185. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Vaday GG, Hua SB, Peehl DM, Pauling MH,
Lin YH, Zhu L, Lawrence DM, Foda HD and Zucker S: CXCR4 and CXCL12
(SDF-1) in prostate cancer: inhibitory effects of human single
chain Fv antibodies. Clin Cancer Res. 10:5630–5639. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Libura J, Drukala J, Majka M, Tomescu O,
Navenot JM, Kucia M, Marquez L, Peiper SC, Barr FG,
Janowska-Wieczorek A, et al: CXCR4-SDF-1 signaling is active in
rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and
adhesion. Blood. 100:2597–2606. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Esencay M, Newcomb EW and Zagzag D: HGF
upregulates CXCR4 expression in gliomas via NF-kappaB: Implications
for glioma cell migration. J Neurooncol. 99:33–40. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wu M, Chen Q, Li D, Li X, Li X, Huang C,
Tang Y, Zhou Y, Wang D, Tang K, et al: LRRC4 inhibits human
glioblastoma cells proliferation, invasion, and proMMP-2 activation
by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling
pathways. J Cell Biochem. 103:245–255. 2008. View Article : Google Scholar
|
|
50
|
Roh J, Muelleman T, Tawfik O and Thomas
SM: Perineural growth in head and neck squamous cell carcinoma: A
review. Oral Oncol. 51:16–23. 2015. View Article : Google Scholar
|
|
51
|
Zhang J, Sarkar S and Yong VW: The
chemokine stromal cell derived factor-1 (CXCL12) promotes glioma
invasiveness through MT2-matrix metalloproteinase. Carcinogenesis.
26:2069–2077. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhu Y, Yang P, Zhang X, Zhang L, Cui G,
Wang Q, Lv L, Zhang Y, Xin X, Yan T, et al: The effect and
mechanism of CXCR4 silencing on metastasis suppression of human
glioma U87 cell line. Anat Rec (Hoboken). 296:1857–1864. 2013.
View Article : Google Scholar
|
|
53
|
Marchesi F, Locatelli M, Solinas G, Erreni
M, Allavena P and Mantovani A: Role of CX3CR1/CX3CL1 axis in
primary and secondary involvement of the nervous system by cancer.
J Neuroimmunol. 224:39–44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Bazan JF, Bacon KB, Hardiman G, Wang W,
Soo K, Rossi D, Greaves DR, Zlotnik A and Schall TJ: A new class of
membrane-bound chemokine with a CX3C motif. Nature. 385:640–644.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J,
Gonzalo JA, Vath J, Gosselin M, Ma J, Dussault B, et al:
Neurotactin, a membrane-anchored chemokine upregulated in brain
inflammation. Nature. 387:611–617. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Verge GM, Milligan ED, Maier SF, Watkins
LR, Naeve GS and Foster AC: Fractalkine (CX3CL1) and fractalkine
receptor (CX3CR1) distribution in spinal cord and dorsal root
ganglia under basal and neuropathic pain conditions. Eur J
Neurosci. 20:1150–1160. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Balkwill FR: Tumour necrosis factor and
cancer. Prog Growth Factor Res. 4:121–137. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zeng Y, Jiang J, Huebener N, Wenkel J,
Gaedicke G, Xiang R and Lode HN: Fractalkine gene therapy for
neuroblastoma is more effective in combination with targeted IL-2.
Cancer Lett. 228:187–193. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Locatelli M, Boiocchi L, Ferrero S,
Martinelli Boneschi F, Zavanone M, Pesce S, Allavena P, Maria Gaini
S, Bello L and Mantovani A: Human glioma tumors express high levels
of the chemokine receptor CX3CR1. Eur Cytokine Netw. 21:27–33.
2010.PubMed/NCBI
|
|
60
|
Marchesi F, Piemonti L, Fedele G, Destro
A, Roncalli M, Albarello L, Doglioni C, Anselmo A, Doni A, Bianchi
P, et al: The chemokine receptor CX3CR1 is involved in the neural
tropism and malignant behavior of pancreatic ductal adenocarcinoma.
Cancer Res. 68:9060–9069. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Andre F, Cabioglu N, Assi H, Sabourin JC,
Delaloge S, Sahin A, Broglio K, Spano JP, Combadiere C, Bucana C,
et al: Expression of chemokine receptors predicts the site of
metastatic relapse in patients with axillary node positive primary
breast cancer. Ann Oncol. 17:945–951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Shulby SA, Dolloff NG, Stearns ME, Meucci
O and Fatatis A: CX3CR1-fractalkine expression regulates cellular
mechanisms involved in adhesion, migration, and survival of human
prostate cancer cells. Cancer Res. 64:4693–4698. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Muller A, Sonkoly E, Eulert C, Gerber PA,
Kubitza R, Schirlau K, Franken-Kunkel P, Poremba C, Snyderman C,
Klotz LO, et al: Chemokine receptors in head and neck cancer:
Association with metastatic spread and regulation during
chemotherapy. Int J Cancer. 118:2147–2157. 2006. View Article : Google Scholar
|
|
64
|
Fang WB, Jokar I, Zou A, Lambert D,
Dendukuri P and Cheng N: CCL2/CCR2 chemokine signaling coordinates
survival and motility of breast cancer cells through Smad3 protein-
and p42/44 mitogen-activated protein kinase (MAPK)-dependent
mechanisms. J Biol Chem. 287:36593–36608. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Dagouassat M, Suffee N, Hlawaty H, Haddad
O, Charni F, Laguillier C, Vassy R, Martin L, Schischmanoff PO,
Gattegno L, et al: Monocyte chemoattractant protein-1 (MCP-1)/CCL2
secreted by hepatic myofibroblasts promotes migration and invasion
of human hepatoma cells. Int J Cancer. 126:1095–1108. 2010.
|
|
66
|
Vaday GG, Peehl DM, Kadam PA and Lawrence
DM: Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
Prostate. 66:124–134. 2006. View Article : Google Scholar
|
|
67
|
Borczuk AC, Papanikolaou N, Toonkel RL,
Sole M, Gorenstein LA, Ginsburg ME, Sonett JR, Friedman RA and
Powell CA: Lung adenocarcinoma invasion in TGFbetaRII-deficient
cells is mediated by CCL5/RANTES. Oncogene. 27:557–564. 2008.
View Article : Google Scholar
|
|
68
|
Singh S, Singh R, Singh UP, Rai SN,
Novakovic KR, Chung LW, Didier PJ, Grizzle WE and Lillard JW Jr:
Clinical and biological significance of CXCR5 expressed by prostate
cancer specimens and cell lines. Int J Cancer. 125:2288–2295. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Qi XW, Xia SH, Yin Y, Jin LF, Pu Y, Hua D
and Wu HR: Expression features of CXCR5 and its ligand, CXCL13
associated with poor prognosis of advanced colorectal cancer. Eur
Rev Med Pharmacol Sci. 18:1916–1924. 2014.PubMed/NCBI
|
|
70
|
El-Haibi CP, Singh R, Sharma PK, Singh S
and Lillard JW Jr: CXCL13 mediates prostate cancer cell
proliferation through JNK signalling and invasion through ERK
activation. Cell Prolif. 44:311–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhu Z, Zhang X, Guo H, Fu L, Pan G and Sun
Y: CXCL13-CXCR5 axis promotes the growth and invasion of colon
cancer cells via PI3K/AKT pathway. Mol Cell Biochem. 400:287–295.
2015. View Article : Google Scholar
|
|
72
|
Kim HJ, Kim JS, Kang CD, Lee SJ, Kim JY,
Yeon JE, Park JJ, Shim JJ, Byun KS, Bak YT, et al: Expression of
epidermal growth factor receptor, ErbB2 and matrix
metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma.
Korean J Gastroenterol. 45:52–59. 2005.In Korean. PubMed/NCBI
|
|
73
|
Duan L, Hu XQ, Feng DY, Lei SY and Hu GH:
GPC-1 may serve as a predictor of perineural invasion and a
prognosticator of survival in pancreatic cancer. Asian J Surg.
36:7–12. 2013. View Article : Google Scholar
|
|
74
|
Itatsu K, Sasaki M, Yamaguchi J, Ohira S,
Ishikawa A, Ikeda H, Sato Y, Harada K, Zen Y, Sato H, et al:
Cyclooxygenase-2 is involved in the up-regulation of matrix
metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis
factor-alpha. Am J Pathol. 174:829–841. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yang X, Dai J, Li T, Zhang P, Ma Q, Li Y,
Zhou J and Lei D: Expression of EMMPRIN in adenoid cystic carcinoma
of salivary glands: Correlation with tumor progression and
patients' prognosis. Oral Oncol. 46:755–760. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Yang X, Zhang P, Ma Q, Kong L, Li Y, Liu B
and Lei D: EMMPRIN contributes to the in vitro invasion of human
salivary adenoid cystic carcinoma cells. Oncol Rep. 27:1123–1127.
2012. View Article : Google Scholar
|
|
77
|
Yang X, Zhang P, Ma Q, Kong L, Li Y, Liu B
and Lei D: EMMPRIN silencing inhibits proliferation and perineural
invasion of human salivary adenoid cystic carcinoma cells in vitro
and in vivo. Cancer Biol Ther. 13:85–91. 2012. View Article : Google Scholar
|
|
78
|
Anton ES, Weskamp G, Reichardt LF and
Matthew WD: Nerve growth factor and its low-affinity receptor
promote Schwann cell migration. Proc Natl Acad Sci USA.
91:2795–2799. 1994. View Article : Google Scholar
|
|
79
|
Zhu Z, Kleeff J, Kayed H, Wang L, Korc M,
Büchler MW and Friess H: Nerve growth factor and enhancement of
proliferation, invasion, and tumorigenicity of pancreatic cancer
cells. Mol Carcinog. 35:138–147. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhu Z, Friess H, diMola FF, Zimmermann A,
Graber HU, Korc M and Büchler MW: Nerve growth factor expression
correlates with perineural invasion and pain in human pancreatic
cancer. J Clin Oncol. 17:2419–2428. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
DeSchryver-Kecskemeti K, Balogh K and Neet
KE: Nerve growth factor and the concept of neural-epithelial
interactions. Immunohistochemical observations in two cases of
vasitis nodosa and six cases of prostatic adenocarcinoma. Arch
Pathol Lab Med. 111:833–835. 1987.PubMed/NCBI
|
|
82
|
Okada Y, Eibl G, Duffy JP, Reber HA and
Hines OJ: Glial cell-derived neurotrophic factor upregulates the
expression and activation of matrix metalloproteinase-9 in human
pancreatic cancer. Surgery. 134:293–299. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Okada Y, Eibl G, Guha S, Duffy JP, Reber
HA and Hines OJ: Nerve growth factor stimulates MMP-2 expression
and activity and increases invasion by human pancreatic cancer
cells. Clin Exp Metastasis. 21:285–292. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Moscatelli I, Pierantozzi E, Camaioni A,
Siracusa G and Campagnolo L: p75 neurotrophin receptor is involved
in proliferation of undifferentiated mouse embryonic stem cells.
Exp Cell Res. 315:3220–3232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wang L, Sun M, Jiang Y, Yang L, Lei D, Lu
C, Zhao Y, Zhang P, Yang Y and Li J: Nerve growth factor and
tyrosine kinase A in human salivary adenoid cystic carcinoma:
expression patterns and effects on in vitro invasive behavior. J
Oral Maxillofac Surg. 64:636–641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Taylor S, Herrington S, Prime W, Rudland
PS and Barraclough R: S100A4 (p9Ka) protein in colon carcinoma and
liver metastases: Association with carcinoma cells and
T-lymphocytes. Br J Cancer. 86:409–416. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Jiang WG: E-cadherin and its associated
protein catenins, cancer invasion and metastasis. Br J Surg.
83:437–446. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Schmidt KN, Amstad P, Cerutti P and
Baeuerle PA: Identification of hydrogen peroxide as the relevant
messenger in the activation pathway of transcription factor
NF-kappaB. Adv Exp Med Biol. 387:63–68. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wang CY, Mayo MW and Baldwin AS Jr: TNF-
and cancer therapy-induced apoptosis: Potentiation by inhibition of
NF-kappaB. Science. 274:784–787. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Huang S, Pettaway CA, Uehara H, Bucana CD
and Fidler IJ: Blockade of NF-kappaB activity in human prostate
cancer cells is associated with suppression of angiogenesis,
invasion, and metastasis. Oncogene. 20:4188–4197. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Huang S, DeGuzman A, Bucana CD and Fidler
IJ: Nuclear factor-kappaB activity correlates with growth,
angiogenesis, and metastasis of human melanoma cells in nude mice.
Clin Cancer Res. 6:2573–2581. 2000.PubMed/NCBI
|
|
92
|
Sun X, Cheng G, Hao M, Zheng J, Zhou X,
Zhang J, Taichman RS, Pienta KJ and Wang J: CXCL12 / CXCR4 / CXCR7
chemokine axis and cancer progression. Cancer Metastasis Rev.
29:709–722. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zheng Y, Miu Y, Yang X, Yang X and Zhu M:
CCR7 Mediates TGF-β1-induced human malignant glioma invasion,
migration, and epithelial-mesenchymal transition by activating
MMP2/9 through the nuclear factor kappaB signaling pathway. DNA
Cell Biol. 36:853–861. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Zhong W, Tong Y, Li Y, Yuan J, Hu S, Hu T
and Song G: Mesenchymal stem cells in inflammatory microenvironment
potently promote metastatic growth of cholangiocarcinoma via
activating Akt/NF-κB signaling by paracrine CCL5. Oncotarget.
8:73693–73704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Wang H, Cai J, Du S, Guo Z, Xin B, Wang J,
Wei W and Shen X: Fractalkine/CX3CR1 induces apoptosis resistance
and proliferation through the activation of the AKT/NF-κB cascade
in pancreatic cancer cells. Cell Biochem Funct. 35:315–326. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Anwar TE and Kleer CG: Tissue-based
identification of stem cells and epithelial-to-mesenchymal
transition in breast cancer. Hum Pathol. 44:1457–1464. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Olmeda D, Montes A, Moreno-Bueno G, Flores
JM, Portillo F and Cano A: Snai1 and Snai2 collaborate on tumor
growth and metastasis properties of mouse skin carcinoma cell
lines. Oncogene. 27:4690–4701. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Carpenter RL, Paw I, Dewhirst MW and Lo
HW: Akt phosphorylates and activates HSF-1 independent of heat
shock, leading to Slug overexpression and epithelial-mesenchymal
transition (EMT) of HER2-overexpressing breast cancer cells.
Oncogene. 34:546–557. 2015. View Article : Google Scholar
|
|
99
|
Hotz B, Arndt M, Dullat S, Bhargava S,
Buhr HJ and Hotz HG: Epithelial to mesenchymal transition:
Expression of the regulators snail, slug, and twist in pancreatic
cancer. Clin Cancer Res. 13:4769–4776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
He Q, Zhou X, Li S, Jin Y, Chen Z, Chen D,
Cai Y, Liu Z, Zhao T and Wang A: MicroRNA-181a suppresses salivary
adenoid cystic carcinoma metastasis by targeting MAPK-Snai2
pathway. Biochim Biophys Acta. 1830:5258–5266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Chang B, Yang H, Jiao Y, Wang K, Liu Z, Wu
P, Li S and Wang A: SOD2 deregulation enhances migration, invasion
and has poor prognosis in salivary adenoid cystic carcinoma. Sci
Rep. 6:259182016. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Wang H, Liang X, Li M, Tao X, Tai S, Fan
Z, Wang Z, Cheng B and Xia J: Chemokine (CC motif) ligand 18
upregulates Slug expression to promote stem-cell like features by
activating the mammalian target of rapamycin pathway in oral
squamous cell carcinoma. Cancer Sci. 108:1584–1593. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Zhong G, Chen L, Yin R, Qu Y, Bao Y, Xiao
Q, Zhang Z, Shen Y, Li C, Xu Y, et al: Chemokine (C-C motif) ligand
21/C-C chemokine receptor type 7 triggers migration and invasion of
human lung cancer cells by epithelial-mesenchymal transition via
the extracellular signal-regulated kinase signaling pathway. Mol
Med Rep. 15:4100–4108. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Li G, Yang Y, Xu S, Ma L, He M and Zhang
Z: Slug signaling is up-regulated by CCL21/CCR7 [corrected] to
induce EMT in human chondrosarcoma. Med Oncol. 32:4782015.
|
|
107
|
Hou X, Zhang Y and Qiao H: CCL18 promotes
the invasion and migration of gastric cancer cells via ERK1/2/NF-κB
signaling pathway. Tumour Biol. 37:641–651. 2016. View Article : Google Scholar
|
|
108
|
Zhao S, Wang J and Qin C: Blockade of
CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma
progression and metastasis via inactivation of canonical Wnt
pathway. J Exp Clin Cancer Res. 33:1032014. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Murre C, McCaw PS, Vaessin H, Caudy M, Jan
LY, Jan YN, Cabrera CV, Buskin JN, Hauschka SD, Lassar AB, et al:
Interactions between heterologous helix-loop-helix proteins
generate complexes that bind specifically to a common DNA sequence.
Cell. 58:537–544. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Ip YT, Park RE, Kosman D, Yazdanbakhsh K
and Levine M: dorsal-twist interactions establish snail expression
in the presumptive mesoderm of the Drosophila embryo. Genes Dev.
6:1518–1530. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C,
Zhang X, Chua CW, Chan KW, Chan FL, Glackin C, et al: Up-regulation
of TWIST in prostate cancer and its implication as a therapeutic
target. Cancer Res. 65:5153–5162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Rosivatz E, Becker I, Specht K, Fricke E,
Luber B, Busch R, Höfler H and Becker KF: Differential expression
of the epithelial-mesenchymal transition regulators snail, SIP1,
and twist in gastric cancer. Am J Pathol. 161:1881–1891. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Wang D, Rai B, Qi F, Liu T, Wang J, Wang X
and Ma B: Influence of the Twist gene on the invasion and
metastasis of colon cancer. Oncol Rep. 39:31–44. 2018.
|
|
115
|
Chen W, Gao Q, Han S, Pan F and Fan W: The
CCL2/CCR2 axis enhances IL-6-induced epithelial-mesenchymal
transition by cooperatively activating STAT3-Twist signaling.
Tumour Biol. 36:973–981. 2015. View Article : Google Scholar
|
|
116
|
Low-Marchelli JM, Ardi VC, Vizcarra EA,
van Rooijen N, Quigley JP and Yang J: Twist1 induces CCL2 and
recruits macrophages to promote angiogenesis. Cancer Res.
73:662–671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Xu C, Liu Y, Xiao L, Guo C, Deng S, Zheng
S and Zeng E: The involvement of anterior gradient 2 in the stromal
cell-derived factor 1-induced epithelial-mesenchymal transition of
glioblastoma. Tumour Biol. 37:6091–6097. 2016. View Article : Google Scholar
|
|
118
|
Koo YJ, Kim TJ, Min KJ, So KA, Jung US and
Hong JH: CXCL11 mediates TWIST1-induced angiogenesis in epithelial
ovarian cancer. Tumour Biol. 39:10104283177062262017. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Li K, Xu B, Xu G and Liu R: CCR7 regulates
Twist to induce the epithelial-mesenchymal transition in pancreatic
ductal adenocarcinoma. Tumour Biol. 37:419–424. 2016. View Article : Google Scholar
|
|
120
|
Franciszkiewicz K, Boissonnas A, Boutet M,
Combadière C and Mami-Chouaib F: Role of chemokines and chemokine
receptors in shaping the effector phase of the antitumor immune
response. Cancer Res. 72:6325–6332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Wang D, Dubois RN and Richmond A: The role
of chemokines in intestinal inflammation and cancer. Curr Opin
Pharmacol. 9:688–696. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Celesti G, Di Caro G, Bianchi P, Grizzi F,
Marchesi F, Basso G, Rahal D, Delconte G, Catalano M, Cappello P,
et al: Early expression of the fractalkine receptor CX3CR1 in
pancreatic carcinogenesis. Br J Cancer. 109:2424–2433. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Schioppa T, Uranchimeg B, Saccani A,
Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni
M, Vago L, et al: Regulation of the chemokine receptor CXCR4 by
hypoxia. J Exp Med. 198:1391–1402. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Ceradini DJ, Kulkarni AR, Callaghan MJ,
Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP
and Gurtner GC: Progenitor cell trafficking is regulated by hypoxic
gradients through HIF-1 induction of SDF-1. Nat Med. 10:858–864.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
125
|
Rong Y, Durden DL, Van Meir EG and Brat
DJ: 'Pseudopalisading' necrosis in glioblastoma: A familiar
morphologic feature that links vascular pathology, hypoxia, and
angiogenesis. J Neuropathol Exp Neurol. 65:529–539. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Lin S, Wan S, Sun L, Hu J, Fang D, Zhao R,
Yuan S and Zhang L: Chemokine C-C motif receptor 5 and C-C motif
ligand 5 promote cancer cell migration under hypoxia. Cancer Sci.
103:904–912. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Li Y, Qiu X, Zhang S, Zhang Q and Wang E:
Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha
correlates with migration and invasion in lung cancer cells. Cancer
Biol Ther. 8:322–330. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Zhao T, Gao S, Wang X, Liu J, Duan Y, Yuan
Z, Sheng J, Li S, Wang F, Yu M, et al: Hypoxia-inducible factor-1α
regulates chemotactic migration of pancreatic ductal adenocarcinoma
cells through directly transactivating the CX3CR1 gene. PLoS One.
7:e433992012. View Article : Google Scholar
|
|
129
|
Xiao LJ, Chen YY, Lin P, Zou HF, Lin F,
Zhao LN, Li D, Guo L, Tang JB, Zheng XL, et al: Hypoxia increases
CX3CR1 expression via HIF-1 and NF-κB in androgen-independent
prostate cancer cells. Int J Oncol. 41:1827–1836. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Trusolino L, Cavassa S, Angelini P, Andó
M, Bertotti A, Comoglio PM and Boccaccio C: HGF/scatter factor
selectively promotes cell invasion by increasing integrin avidity.
FASEB J. 14:1629–1640. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Matteucci E, Modora S, Simone M and
Desiderio MA: Hepatocyte growth factor induces apoptosis through
the extrinsic pathway in hepatoma cells: Favouring role of
hypoxia-inducible factor-1 deficiency. Oncogene. 22:4062–4073.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Zhang YW, Su Y, Volpert OV and Vande Woude
GF: Hepatocyte growth factor/scatter factor mediates angiogenesis
through positive VEGF and negative thrombospondin 1 regulation.
Proc Natl Acad Sci USA. 100:12718–12723. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Tacchini L, De Ponti C, Matteucci E,
Follis R and Desiderio MA: Hepatocyte growth factor-activated
NF-kappaB regulates HIF-1 activity and ODC expression, implicated
in survival, differently in different carcinoma cell lines.
Carcinogenesis. 25:2089–2100. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Niu G and Chen X: Vascular endothelial
growth factor as an anti-angiogenic target for cancer therapy. Curr
Drug Targets. 11:1000–1017. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Owusu BY, Galemmo R, Janetka J and
Klampfer L: Hepatocyte growth factor, a key tumor-promoting factor
in the tumor microenvironment. Cancers (Basel). 9:92017. View Article : Google Scholar
|
